Sign In
Step 1
Unite with Fellow Investors
Step 2
Choose the Best Attorney
Step 3
Provide Documents
Step 4
Follow Case Progress
Step 5
Get Payout
NEXI.US

NexImmune (NEXI) Stock Halted Case

  • On December 1st, 2023, $NEXI surged over 300%, leading Nasdaq to halt trading.
  • NexImmune has faced a significant decline since its 2021 IPO.
  • With concerns about dissolution, $NEXI didn't trade on Friday.
NexImmune proposes on December 21 meeting for shareholder approval of liquidation. The board unanimously supports dissolution after evaluating strategic options and the company's financial status.

Trouble emerged in September with NexImmune reducing its workforce and pausing clinical trials.

Despite this, $NEXI surged 35% between November 27 and 30, prompting Nasdaq's intervention.
Alleged Offence
Mismanagement
Misleading Statements
Omissions
Suspected Party
Directors
Management
Security Type
Stocks
Trade Direction
Long
Shock Event Date
01 December 2023
Collecting participants…
Created by Polina Foster, Scout

Neximmune Inc

NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It dev...

    Ticker
    NEXI.US
    ISIN
    US65344D1090
    CIK
    1538210
    Sector
    Healthcare
    Industry
    Biotechnology
    Country
    USA
    Address
    9119 Gaither Road, Gaithersburg, MD, United States, 20877